Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
Trial Parameters
Brief Summary
The early identification and severe warning of acute respiratory infectious diseases are of paramount importance. Utilizing effective means to make correct diagnoses of the source of infection at an early stage is the premise of all effective measures. AI-MID is a research initiative that uses artificial intelligence tools to assist in the clinical medical imaging diagnosis of respiratory diseases, aiming to reduce the time doctors spend reviewing images, increase work efficiency, and enhance the sensitivity and specificity of pneumonia detection, thereby improving the detection rate of pneumonia at the grassroots level. This approach facilitates precise prevention, accurate diagnosis, and precise treatment.
Eligibility Criteria
Inclusion Criteria: 1. 1-90 years old, gender not specified. 2. Exhibits symptoms of respiratory tract infection 3. Must have etiological examination results 4. Must have imaging data; Exclusion Criteria: 1. Severe artifacts in medical images 2. Clinical diagnosis indicates concurrent pulmonary edema 3. Dual review results in unclear diagnosis or potential misdiagnosis 4. Other situations that may cause difficulties in reading the films, or as determined by the researcher, the study participant is deemed unsuitable for enrollment.